Skip to content

Effects of mindfulness-based interventions on depressive symptoms in patients with substance use disorders: a systematic review and meta-analysis

Chuntana Reangsing, Sasinun Pusuwun, Suneerat Boonsin, Sarah Oerther

Frontiers of Nursing June 1, 2023 DOI: 10.2478/fon-2023-0016 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review and meta-analysis Peer reviewed
Sample size 1,352
Population Patients with substance use disorders and depression
Intervention Mindfulness-based interventions
Topics Addiction Depression Meditation
Key findings Mindfulness-based interventions significantly reduced depressive symptoms in patients with substance use disorders compared with controls (Hedges' g = 0.67, 95% CI 0.29 to 1.05), with high heterogeneity (I² = 89%). Combining individual and group formats produced a larger effect (g = 2.13) than group-only (g = 0.64) or individual-only (g = 0.33) delivery. The authors conclude that MBIs may be used as an adjunctive or alternative to conventional treatment for depressed patients with SUDs.

Abstract

Abstract Objective We examined the effects of mindfulness-based interventions (MBIs) on depressive symptoms in patients with substance use disorders (SUDs) and explored the moderating effects of participant, method, and intervention characteristics.

Methods: We systematically searched 8 databases from their inception till November 2021. The inclusion criteria were primary studies evaluating MBIs in patients with SUDs with depression measured as an outcome, those including a control group, and those written in English. We used a random-effects model to compute effect sizes (ESs) using Hedges’ g, a forest plot, and Q and I 2 statistics as measures of heterogeneity; we also examined moderator analyses.

Results: Nineteen studies included 1352 participants (age: 38.6 ± 7.0 years). Overall, MBIs showed significantly improved depression ( g = 0.67, 95% confidence interval [CI]: 0.29, 1.05, I 2 = 89%) compared to controls. With regard to moderators, providing MBIs as an individual plus group intervention had a greater effect ( g = 2.13) on reducing depressive symptoms than providing MBIs as a group intervention ( g = 0.64) or an individual intervention only ( g = 0.33, P = 0.034). Using concealed allocation tended to reduce depressive symptoms ( g = 1.22) as compared to not using concealed allocation ( g = 0.48, P = 0.086). No other quality indicators were demonstrated to have a moderating influence on the value of the ES.

Conclusions: MBIs improved depressive symptoms in patients with SUDs. MBIs might be used as an adjunctive or alternative to conventional treatment for depressed patients with SUDs.

Comparable studies

Other systematic reviews and meta-analyses on addiction, most cited first.

Study Year Design Participants
Ketamine use: a review Ketamine users 2011 Systematic review
Mindfulness Meditation for Substance Use Disorders: A Systematic Review Individuals with substance use disorders 2009 Systematic review
Mindfulness-Based Interventions for the Treatment of Substance and Behavioral Addictions: A Systematic Review 2018 Systematic review
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review 2021 Systematic review
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials Patients with psychiatric disorders, primarily alcoholism 2020 Systematic review n = 567

Citations in the library

Explore topics